Lochner Daniel
- SEC CIK
- 0001791187
In the past year, 1 open-market purchase filing worth $129.7K and no sales.
Current role at each company
- TECX Tectonic Therapeutic, Inc.Chief Financial Officeras of Sep 8, 2026
- OYST Oyster Point Pharma, Inc.Chief Financial Officeras of Jan 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $129.7K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$129.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lochner Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TECX Tectonic Therapeutic, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 (view filing) | Feb 10 | 1 day | Lochner DanielChief Financial Officer | PPurchase | +6.00K | $21.61 | +$129.7K | +23.0%32.0K after | |
| Feb 7, 2025 (view filing) | Feb 5 | 2 days | Lochner DanielChief Financial Officer | PPurchase | +4.62K | $54.14 | +$250.0K | New position4.62K after |